| abstract |
Disclosed herein is a cinnamide compound of formula (I), wherein the substituents are as defined in the disclosure, which is useful for treating diseases caused by amyloid beta, such as Alzheimers disease, senile dementia, Down syndrome, or amyloidosis. |